Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open, Multicenter Observational Study of Docetaxel Utilized in Mono- or Combination Therapy for Treatment of Breast Cancer, NSCLC, Prostate Carcinoma, Adenocarcinoma of Stomach and Advanced Squamous Cell Carcinoma of Head/Neck Region.

NCT01614002 is registered in ClinicalTrials.gov with Onkovis GmbH as lead sponsor.

NCT NCT01614002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01614002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open, Multicenter Observational Study of Docetaxel Utilized in Mono- or Combination Therapy for Treatment of Breast Cancer, NSCLC, Prostate Carcinoma, Adenocarcinoma of Stomach and Advanced Squamous Cell Carcinoma of Head/Neck Region.
Lead sponsor
Onkovis GmbH
Phase
Observational
Overall status
Completed
Start date
May 31, 2012
Completion date
March 31, 2015
Enrollment
371 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma